A. Noda et al., EFFECT OF DIMETHADIONE ADMINISTERED INTRAVENOUSLY ON PANCREATIC-SECRETION IN DOGS, Journal of gastroenterology and hepatology, 9(5), 1994, pp. 486-491
In order to detect both pancreatic excretion of dimethadione (DMO), a
weak organic acid, and the effect of pancreatic DMO on secretin-stimul
ated pancreatic secretion, DMO was given intravenously to dogs with pa
ncreatic fistulae at a dose of 50, 100 and 200 mg/kg. DMO was promptly
excreted into pancreatic juice; the concentration decreased exponenti
ally as it did in plasma at the highest dose of the compound. Ar equil
ibrium of DMO between pancreatic juice and plasma, the DMO concentrati
on in the juice depended directly on that in plasma; the juice/plasma
concentration ratios for DMO exceeded 1.0, ranging from 1.7 to 2.1. Pa
ncreatic DMO caused a small but significant decrease in the water, bic
arbonate and sodium secretion at non-equilibrium, and in the bicarbona
te secretion at equilibrium. A decrease in the bicarbonate secretion m
ay result largely from the buffer action of bicarbonate on protons pro
vided by the undissociated form of DMO. The sum of both bicarbonate an
d chloride concentrations in pancreatic juice decreased with the incre
ased DMO concentration in the juice, implying that DMO may compete wit
h the secretion of bicarbonate and/or chloride across the apical membr
ane of the duct cell. Pancreatic DMO can act as a non-specific inhibit
or of pancreatic water and electrolyte secretions.